Benzinga's Top #PreMarket Gainers

Anika Therapeutics ANIK soared 36.21% to $46.95 in the pre-market trading after the company received marketing approval for MONOVISC® from the FDA. TASER International TASR surged 11.41% to $21.25 in the pre-market session after the company reported upbeat Q4 results. Dyax DYAX shares gained 10.26% to $11.18 in the pre-market after the company announced positive results from phase 1a clinical trial of DX-2930. IMRIS IMRS shares jumped 7.06% to $2.88 in pre-market trading after the company received the Australian regulatory clearance for intraoperative CT solution.